P389 Efficacy of once a day multi matrix mesalamine formulation, lialda in patients with active mild to moderate ulcerative colitis after inadequate response to the pH-dependent release mesalamine formulation, asacol
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.